Novel discovery could lead to new cancer, autoimmune disease therapy – Work led by incoming LSI Director and PI, Dr Josef Penninger

A new discovery by an international research team—co-led by UBC Canada 150 Research Chair Josef Penninger and Harvard Medical School neurobiologist Clifford Woolf—could have implications for therapies for cancer and autoimmune diseases.

Read the full UBC release here.